Nervonik
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Los Angeles, California, United StatesWebsite
www.nervonik.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nervonik
Nervonik, Inc., founded in 2020, is a privately held medical device company headquartered in Los Angeles, California. The company specializes in developing miniaturized neuromodulation implants designed to treat chronic neuropathic pain by targeting the peripheral nervous system. These implants utilize advanced neural-sensing integrated circuits to deliver optimized, non-narcotic therapy, aiming to improve patients' quality of life.Explore more
Nervonik Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nervonik your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Nervonik
Earning: See what the market has to say on Nervonik recently announced quarterly report
Check out if Nervonik is spiking on competitors!
Check if Nervonik has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Nervonik launches new products
Funding: Get notified immidiatlly once Nervonik has new funding data
Click to see if Nervonik had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Nervonik, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Nervonik
Compare insights from companies similar to Nervonik, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nervonik is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nervonik is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nervonik.
Nervonik financials insights
Gather financial insights about Nervonik, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$13M
2026
Series B
$52.5M
Nervonik Tech Stack
A closer look at the technologies used by Nervonik
See more technologies
Most Recent Scoops
Funding
Funding
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Nervonik News & Media
Nervonik Announces $52.5 Million Series B Financing to Advance Peripheral Nerve Stimulation Therapy
LOS ANGELES, April 27, 2026 /PRNewswire/ -- Nervonik, Inc., a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, today announced the closing of an oversubscribed $52.5 million Series B financing. The round was led by Amzak...Nervonik Successfully Completes Preclinical Testing of Neural Sensing During Peripheral Nerve Stimulation (PNS) in Large Animal Models
Proprietary waveform and hardware enable real-time neural sensing during stimulation, paving the way for multiple bio-sensing innovations in Peripheral Nerve Stimulation, including future closed-loop therapies. LOS ANGELES, Sept. 16, 2025 /PRNewswire/ -- Nervonik Inc., a neuromodulation...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nervonik
Sign Up For FreeTo access detailed company insights
Nervonik, Inc., founded in 2020, is a privately held medical device company headquartered in Los Angeles, California. The company specializes in developing miniaturized neuromodulation implants designed to treat chronic neuropathic pain by targeting the peripheral nervous system. These implants utilize advanced neural-sensing integrated circuits to... Read More
